Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.

Precigen, Inc. ( PGEN) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 10:30 AM EST ...

SAN FRANCISCO – Alteogen, the most valuable biotech firm listed on Korea’s tech-heavy Kosdaq, is nearing another major ...

I think they’re just saying whatever they need to say right now to get approval,” Columbus resident Karlene Forbes told the ...

It was at this meeting that Miller received the Lifetime Achievement Award from City Manager Rob Boyer. Miller originally ...

Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock ...

Stoke Therapeutics advances TANGO ASO for Dravet, with Zorevunersen Phase 3 data showing seizure reduction and a delayed 2027 ...

Vail Resorts Inc. downgraded its financial projections after an extremely dry and warm start to the 2025-2026 ski season ...

Learn how to recognize ARFID signs, such as fear or sensory issues around food. See how empowered families can support ...

More houses will sell in Northern Colorado than a year ago and the median resale price will continue to escalate, but not at the levels that the market saw over the past decade or more.

Neurocrine Biosciences, Inc. today announced the presentation of the first head-to-head data comparing vesicular monoamine transporter 2 (VMAT2) target occupancy between INGREZZA® (valbenazine) ...